Clinical Trial Update: Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial [Phase 1, Phase 2]

View source ↗

Summary

The CuRe Trial is a Phase 1/2 clinical study evaluating a cellular therapy for in utero repair of myelomeningocele, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomeningocele

Drugs mentioned

• CuRe Trial Cellular Therapy

Snippet

Sponsor: University of California, Davis | Conditions: Myelomeningocele | Phase 1, Phase 2 | Status: RECRUITING